產(chǎn)品詳情
簡單介紹：
Anti-FRAT2抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-FRAT2抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-FRAT2
Cat. Number:
Anti-FRAT2抗體KL-12435R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significantAnti-FRAT2抗體 homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins.
Also known as:
Frequently rearranged in advanced Anti-FRAT2抗體T-cell lymphomas 2 antibodyGSK-3 binding protein FRAT2; FRAT2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FRAT2.
●
Predicted Molecular Weight: 24kDa.Anti-FRAT2抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-FRAT2抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl650Ra01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl650Po01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl908Ge01 褪黑素(MT)多克隆抗體 Polyclonal Antibody to Melatonin (MT)
kl575Hu01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Ra01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Rb51 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Bo01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl095Hu01 粘蛋白(MUC)多克隆抗體 Polyclonal Antibody to Mucin (MUC)
kl095Po01 粘蛋白(MUC)多克隆抗體 Polyclonal Antibody to Mucin (MUC)
kl480Ca01 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl480Ga01 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl098Hu01 肌漿球蛋白(Myo)多克隆抗體 Polyclonal Antibody to Myosin(Myo)
kl098Rb51 肌漿球蛋白(Myo)多克隆抗體 Polyclonal Antibody to Myosin(Myo)
kl218Ge01 **脫落酸(ABA)多克隆抗體 Polyclonal Antibody to Abscisic Acid (ABA)
kl907Ge01 去甲腎上腺素(NE)多克隆抗體 Polyclonal Antibody to Noradrenaline (NE)
kl121Ge01 **肽(OP)多克隆抗體 Polyclonal Antibody to Opioid Peptide (OP)
kl115Pl01 多酚氧化酶(PPO)多克隆抗體 Polyclonal Antibody to Polyphenol Oxidase (PPO)
